Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method including 25 novel synthetic opioids in hair and subsequent analysis of a Swiss opioid consumer cohort.
LC-MS/MS
NSOs
Switzerland
fentanyl
hair analysis
Journal
Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449
Informations de publication
Date de publication:
21 Feb 2024
21 Feb 2024
Historique:
revised:
22
01
2024
received:
15
12
2023
accepted:
01
02
2024
medline:
21
2
2024
pubmed:
21
2
2024
entrez:
21
2
2024
Statut:
aheadofprint
Résumé
Major public health concern is raised by the evidence that common drugs like heroin are now frequently laced or replaced with highly potent novel synthetic opioids (NSOs). The objective of this study was to explore the prevalence and patterns of NSOs in a cohort of Swiss opioid users by hair analysis. Hair analysis is considered an ideal tool for retrospective consumption monitoring. Hair samples from 439 opioid users in Zurich were analyzed. Study inclusion required a previous positive hair test result for heroin metabolites, oxycodone, fentanyl, methadone, or tramadol. The samples were extracted with a two-step extraction procedure, followed by a targeted LC-MS/MS (QTRAP® 6500+) analysis in multiple reaction monitoring mode for a total of 25 NSOs. The method underwent full validation and demonstrated good selectivity and sensitivity with limits of detection (LOD) as low as 0.1 pg/mg. The analyzed sample cohort demonstrated a positivity rate for NSOs of 2.5%, including the following NSOs: butyrylfentanyl, acrylfentanyl, furanylfentanyl, methoxyacetylfentanyl, ocfentanil, U-47700, isobutyrylfentanyl and benzylfentanyl. Furthermore, we were able to identify specific consumption patterns among drug users. The results indicate that hair analysis is a valuable tool for investigating the prevalence of NSOs in drug-using populations, which seems to be low in the case of Swiss opioid users. Nevertheless, the results highlight the need for sensitive analytical detection methods in forensic toxicology to identify and monitor substance distribution in different populations.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Swiss National Science Foundation
ID : IZSEZ0_188514/1
Pays : Switzerland
Informations de copyright
© 2024 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.
Références
Maurer HH, Brandt SD. New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology. Vol. 252. Springer International Publishing; 2018. doi:10.1007/978-3-030-10561-7
Karila L, Marillier M, Chaumette B, Billieux J, Franchitto N, Benyamina A. New synthetic opioids: Part of a new addiction landscape. Neurosci Biobehav Rev. 2019;106:133-140. doi:10.1016/j.neubiorev.2018.06.010
Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology. 2018;134:20171014. doi:10.1016/j.neuropharm.2017.10.016
Administration DE. DEA Releases 2016 Drug Threat Assessment: Fentanyl-related Overdose Deaths Rising At An Alarming Rate. 2016. https://www.dea.gov/press-releases/2016/12/06/dea-releases-2016-drug-threat-assessment-fentanyl-related-overdose-deaths. Accessed September 25, 2023.
Brockbals L, Staeheli SN, Gentile S, et al. Fatal poisoning involving cyclopropylfentanyl-investigation of time-dependent postmortem redistribution. Forensic Sci Int. 2019;294:80-85. doi:10.1016/j.forsciint.2018.11.007
Mueller F, Bogdal C, Pfeiffer B, et al. Isotonitazene: Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland. Forensic Sci Int. 2021;320:110686. doi:10.1016/j.forsciint.2021.110686
Staeheli SN, Baumgartner MR, Gauthier S, et al. Time-dependent postmortem redistribution of butyrfentanyl and its metabolites in blood and alternative matrices in a case of butyrfentanyl intoxication. Forensic Sci Int. 2016;266:170-177. doi:10.1016/j.forsciint.2016.05.034
Drogeninformationszentrum. Kompetenzzentrum für Freizeitdrogenkonsum. 2023. https://www.stadt-zuerich.ch/diz. Accessed September 25, 2023.
Mercolini L, Protti M. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis. J Pharm Biomed Anal. 2016;130:202-219. doi:10.1016/j.jpba.2016.06.046
Kintz P. Value of the concept of minimal detectable dosage in human hair. Forensic Sci Int. 2012;218(1-3):28-30. doi:10.1016/j.forsciint.2011.10.018
Larabi IA, Martin M, Etting I, Pfau G, Edel Y, Alvarez JC. Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: application to 137 authentic samples. Drug Test Anal. 2020;12(9):1298-1308. doi:10.1002/dta.2868
Scholz C, Cabalzar J, Kraemer T, Baumgartner MR. A comprehensive multi-analyte method for Hair analysis: substance-specific quantification ranges and tool for task-oriented data evaluation. J Anal Toxicol. 2021;45(7):701-712. doi:10.1093/jat/bkaa131
Scholz C, Baumgartner MR, Kraemer T, Binz TM. Single sample preparation for the simultaneous extraction of drugs, pharmaceuticals, cannabinoids and endogenous steroids in hair. Anal Methods. 2022;14(44):4583-4591. doi:10.1039/d2ay01325h
Gesellschaft für Toxikologische und Forensische Chemie. Anhang C zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. https://www.gtfch.org/cms/images/stories/media/tk/tk76_3/richtlinieanhangc2009-06-01.pdf. Accessed September 25, 2023.
Gesellschaft für Toxikologische und Forensische Chemie. Anhang C zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. https://www.gtfch.org/cms/images/stories/media/tk/tk76_3/richtlinieanhangb2009-06-01.pdf. Accessed September 25, 2023.
Ramírez Fernández MDM, Wille SMR, Jankowski D, Hill V, Samyn N. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users. Forensic Sci Int. 2020;307:110137. doi:10.1016/j.forsciint.2019.110137
Salomone A, Palamar JJ, Bigiarini R, Gerace E, Di Corcia D, Vincenti M. Detection of fentanyl analogs and synthetic opioids in real hair samples. J Anal Toxicol. 2019;43(4):259-265. doi:10.1093/jat/bky093
Freni F, Moretti M, Radaelli D, et al. Determination of fentanyl and 19 derivatives in hair: application to an Italian population. J Pharm Biomed Anal. 2020;189:113476. doi:10.1016/j.jpba.2020.113476
Zhao K, Dai Y, Wang Y, et al. Quantification of the benzimidazole opioid analog isotonitazene in human hair using liquid chromatography-tandem mass spectrometry. Leg Med (Tokyo). 2023;64:102295. doi:10.1016/j.legalmed.2023.102295
Busardò FP, Carlier J, Giorgetti R, et al. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair. Front Chem. 2019;7:184. doi:10.3389/fchem.2019.00184
Boumba VA, Di Rago M, Peka M, Drummer OH, Gerostamoulos D. The analysis of 132 novel psychoactive substances in human hair using a single step extraction by tandem LC/MS. Forensic Sci Int. 2017;279:192-202. doi:10.1016/j.forsciint.2017.08.031
Federal Department of Home Affairs. Ordinance of the FDHA on the lists of narcotics, psychotropic substances, precursors and auxiliary chemicals. https://www.fedlex.admin.ch/eli/cc/2011/363/de. Accessed September 25, 2023.
Bilel S, Azevedo Neto J, Arfè R, et al. In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl. Neuropharmacology. 2022;209:109020. doi:10.1016/j.neuropharm.2022.109020
Guerrieri D, Rapp E, Roman M, Thelander G, Kronstrand R. Acrylfentanyl: another new psychoactive drug with fatal consequences. Forensic Sci Int. 2017;277:e21-e29. doi:10.1016/j.forsciint.2017.05.010
Adamowicz P, Bakhmut Z, Mikolajczyk A. Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry. J Appl Toxicol. 2020;40(8):1033-1046. doi:10.1002/jat.3962
Poklis J, Poklis A, Wolf C, et al. Two fatal intoxications involving Butyryl fentanyl. J Anal Toxicol. 2016;40(8):703-708. doi:10.1093/jat/bkw048
Coopman V, Cordonnier J, De Leeuw M, Cirimele V. Ocfentanil overdose fatality in the recreational drug scene. Forensic Sci Int. 2016;266:469-473. doi:10.1016/j.forsciint.2016.07.005
Casati S, Minoli M, Angeli I, Ravelli A, Crudele GDL, Orioli M. An ocfentanil-related death case: UHPLC-MS/MS analysis of the drug. Drug Test Anal. 2019;11(1):173-177. doi:10.1002/dta.2473
European Monitoring Centre for Drugs and Drug Addiction. Furanylfentanyl. https://www.emcdda.europa.eu/publications/joint-reports/furanylfentanyl_en. Accessed September 25, 2023.
Nash C, Butzbach D, Stockham P, et al. A fatality involving furanylfentanyl and MMMP, with presumptive identification of three MMMP metabolites in urine. J Anal Toxicol. 2019;43(4):291-298. doi:10.1093/jat/bky099
Swanson DM, Hair LS, Strauch Rivers SR, et al. Fatalities involving carfentanil and furanyl fentanyl: two case reports. J Anal Toxicol. 2017;41(6):498-502. doi:10.1093/jat/bkx037
Gasperini S, Bilel S, Cocchi V, Marti M, Lenzi M, Hrelia P. The genotoxicity of acrylfentanyl, ocfentanyl and furanylfentanyl raises the concern of long-term consequences. Int J Mol Sci. 2022;23(22):14406. doi:10.3390/ijms232214406
Kronstrand R, Åstrand A, Watanabe S, Gréen H, Vikingsson S. Circumstances, postmortem findings, blood concentrations and metabolism in a series of methoxyacetylfentanyl-related deaths. J Anal Toxicol. 2021;45(8):760-771. doi:10.1093/jat/bkab053
European Monitoring Centre for Drugs and Drug Addiction. Methoxyacetylfentanyl. https://www.emcdda.europa.eu/publications/joint-reports/methoxyacetylfentanyl_en. Accessed September 25, 2023.
Ferrari Júnior E, Leite BHM, Gomes EB, Vieira TM, Sepulveda P, Caldas ED. Fatal cases involving new psychoactive substances and trends in analytical techniques. Front Toxicol. 2022;4:1033733. doi:10.3389/ftox.2022.1033733